例如:"NBL1", "4681", "drought"
收藏
3902 LAG3

3902

LAG3

lymphocyte activating 3

protein-coding

Homo sapiens

基因描述

Type Description
Definition lymphocyte activating 3

研究结论

Date Results Publications
2021-04-17 13:17:00 Molecular characterization of HLA class II binding to the LAG-3 T cell co-inhibitory receptor. 32920841
2021-04-03 13:34:00 LAG-3, TIM-3 and VISTA Expression on Tumor-Infiltrating Lymphocytes in Oropharyngeal Squamous Cell Carcinoma-Potential Biomarkers for Targeted Therapy Concepts. 33396515
2021-03-27 14:40:00 LAG-3 and GAL-3 in Endometrial Carcinoma: Emerging Candidates for Immunotherapy. 32267656
2021-03-27 14:39:00 Association of Multiple Sclerosis Phenotypes with of IL7R, LAG3, and CD40 Genes in a Jordanian Population: A Genotype-Phenotype Study. 32111053
2021-01-23 12:58:00 T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple Myeloma. 31445183

名称对应

Type IDs
Synonymous CD223
Gene
UniProtKB-ID: LAG3_HUMAN
UniprotKB: P18627
UniParc: UPI000019B17D, UPI000013C645
EMBL: CH471116, BC052589, X51985, AC125494, AK292104
Ensembl: ENSG00000089692
KO: hsa:3902
Nucleutide sequences
EMBL-CDS: EAW88741.1, BAF84793.1, CAA36243.3, AAH52589.1
Ensembl_TRS: ENST00000441671, ENST00000203629
Protein sequencees
Ensembl_PRO: ENSP00000413825, ENSP00000203629
RefSeq: XP_011519258.1, NP_002277.4
Others
UniRef100: UniRef100_P18627
UniRef90: UniRef90_P18627
UniRef50: UniRef50_P18627
UniGene: Hs.409523
CCDS: CCDS8561.1

全选

{{proteinIndex+1}}
mRNA Protein UniprotKB Description
Refseq {{protein.nucleotideVersion}}

Ensembl: {{protein.nucleotideEnsembl}}

{{protein.proteinVersion}}

Ensembl: {{protein.proteinEnsembl}}

{{uniprot}}
Definition: {{{protein.definition}}}

Transcript Veriant:{{protein.transcriptVeriant}}

Status: {{protein.status}}

Location ( {{protein.positionStart}}..{{protein.positionEnd}} )

暂无数据

研究热度

热点单位
排名 科研单位 文献
{{affIndex+1}}

{{aff.value}}

{{aff.size}}

目前还没有研究热点单位

热点人员
排名 研究人员 文献
{{authorIndex+1}}

{{author.value}}

{{author.size}}

目前还没有研究热点人员